Solid Lipid Microparticles Produced by Spray Congealing: influence of the Atomizer on Microparticle Characteristics and Mathematical Modeling of the Drug Release

Department of Pharmaceutical Sciences, University of Bologna, Bologna, Italy.
Journal of Pharmaceutical Sciences (Impact Factor: 2.59). 11/2009; 99(2):916-31. DOI: 10.1002/jps.21854
Source: PubMed


The first aim of the work was to evaluate the effect of atomizer design on the properties of solid lipid microparticles produced by spray congealing. Two different air atomizers have been employed: a conventional air pressure nozzle (APN) and a recently developed atomizer (wide pneumatic nozzle, WPN). Milled theophylline and Compritol 888ATO were used to produce microparticles at drug-to-carrier ratios of 10:90, 20:80, and 30:70 using the two atomizers. The results showed that the application of different nozzles had significant impacts on the morphology, encapsulation efficiency, and drug release behavior of the microparticles. In contrast, the characteristics of the atomizer did not influence the physicochemical properties of the microparticles as differential scanning calorimetry, Hot Stage microscopy, X-ray powder diffraction, and Fourier transform infrared spectroscopy analysis demonstrated. The drug and the lipid carrier presented in their original crystalline forms in both WPN and APN systems. A second objective of this study was to develop a novel mathematical model for describing the dynamic process of drug release from the solid lipid microparticles. For WPN microparticles the model predicted the changes of the drug release behavior with particle size and drug loading, while for APN microparticles the model fitting was not as good as for the WPN systems, confirming the influence of the atomizer on the drug release behavior.

Download full-text


Available from: Sheng Qi
  • Source
    • "friendly and less time-and energy-consuming than spray drying and other techniques (Passerini et al., 2010). Spray congealing has been successfully employed in the preparation of SLMs to increase the solubility of Biopharmaceutics Classification System Class II drugs and the controlled release of active pharmaceutical ingredients (Fini et al., 2002; Maschke et al., 2007; Ilic et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Purpose: Solid-lipid microparticles loaded with high amounts of the sunscreen UV filter benzophenone-3 were prepared by spray congealing with the objective of decreasing its skin penetration and evaluate whether the sunscreen's photoprotection were impaired by the microencapsulation process. Methods: The microparticles were produced using the natural lipids carnauba wax or bees wax and three different concentrations of benzophenone-3 (30, 50 and 70%) using spray congealing technique. Results: The microparticles presented properties suitable for topical application, such as spherical morphology, high encapsulation efficiency (95.53-102.2%), average particle sizes between 28.5 and 60.0 µm with polydispersivities from 1.2 to 2.5. In studies of in vitro skin penetration and preliminary stability, formulations of gel cream containing carnauba wax solid lipid microparticles and 70% benzophenone-3 when compared to the formulation added of bees wax solid-lipid microparticles containing 70% benzophenone-3, was stable considering the several parameters evaluated and were able to decrease the penetration of the UV filter into pig skin. Moreover, the formulations containing solid lipid microparticles with 70% benzophenone-3 increased the photoprotective capacity of benzophenone-3 under UV irradiation. Conclusion: The results show that spray-congealed microparticles are interesting solid forms to decrease the penetration solar filters in the skin without compromising their photoprotection.
    Full-text · Article · Apr 2014 · Journal of Microencapsulation
  • Source
    • "SLMs based on glyceryl behenate with a theoretical drug loading of 5% and 25% (w/w) were prepared by the spray congealing process using the wide pneumatic nozzle (WPN), which has been fully described in recently published papers (Albertini et al., 2008; Passerini et al., 2010). Briefly, WPN is a two fluid atomizer with a wide orifice opening and equipped with a thermostated reservoir. "
    [Show abstract] [Hide abstract]
    ABSTRACT: An original formulative/manufacturing approach for the development of a multi-composite wound dressing able to control the release of a water soluble API (lidocaine HCl) for several days was evaluated. The prepared multi-composite wound dressing is a microstructured spongy matrix, which embeds solid lipid microparticles (SLMs). The matrices were obtained by freeze drying of polyelectrolyte complexes made up two biopolymers: three different chitosan to alginate weight ratios (1:1, 3:1 and 1:3) were studied. The drug-loaded matrices were investigated as regards water uptake ability, swelling, drug loading, morphology and release profiles. SLMs were prepared at two different drug loadings (5% and 25%, w/w) by the spray congealing technology and were then incorporated in the spongy matrices. The characterization of the SLMs evidenced their spherical shape, mean dimensions lower than 20μm, controlled release and the modification of the drug crystalline state. Comparing the release profiles of the SLMs-loaded sponges, the matrices with 1:3 chitosan/alginate ratio displayed a sustained release profile with the lower burst effect. Then hyaluronan and cysteine were embedded into the matrix to enhance the wound healing properties of the dressing. The final multi-composite platform was able to promote the growth of fibroblasts maintaining its prolonged release characteristic.
    Full-text · Article · Jun 2012 · International Journal of Pharmaceutics
  • Source
    • "Microparticles with a theoretical drug loading of 10% and 20% w/w were produced by the spray congealing process using the wide pneumatic nozzle (WPN), which has been fully described in recently published papers (Albertini et al., 2008, 2009; Passerini et al., 2010). Briefly, WPN is a two fluid atomizer equipped with a thermostated reservoir with a wide orifice opening. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The two-part article aimed to investigate poloxamer 407-based microspheres as a novel platform for enhancing and controlling the delivery of atenolol across the oromucosal tissue. In the Part I of the work, atenolol-loaded poloxamers 407 microparticles were prepared by the solvent free spray congealing technology. This approach was feasible upon the high viscosity of the systems allowing for high loaded (20% w/w) non-aggregated microspheres. Several formulations were studied and the results demonstrated that the drug release patterns, solubility data, mucoadhesion to buccal tissue and gelling properties in saliva could be modified by adding different amount of an amphiphilic polymer-lipid excipient (Gelucire(®) 50/13) to poloxamer 407. Particularly, microspheres based only on poloxamer 407 exhibited very high solubility, mucoadhesive strength and gelling behaviour. To assess their potential as matrix for buccal application, the gelling property and the drug release from tablets obtained from direct compression of the microparticles were further evaluated. The microspheres were then characterized by differential scanning calorimetry, X-ray powder diffraction and Fourier transform-infrared spectra analysis. No solid state modifications and chemical interactions were detectable in the microspheres after manufacturing and during storage, suggesting their stability and use as orotransmucosal delivery systems.
    Full-text · Article · Oct 2010 · International Journal of Pharmaceutics
Show more